78 related articles for article (PubMed ID: 15239124)
41. Bromodeoxyuridine increases keratin 19 protein expression at a posttranscriptional level in two human lung tumor cell lines.
Meleady P; Clynes M
In Vitro Cell Dev Biol Anim; 2001 Sep; 37(8):536-42. PubMed ID: 11669288
[TBL] [Abstract][Full Text] [Related]
42. Human lung carcinoma cell line DLKP contains 3 distinct subpopulations with different growth and attachment properties.
McBride S; Meleady P; Baird A; Dinsdale D; Clynes M
Tumour Biol; 1998; 19(2):88-103. PubMed ID: 9486560
[TBL] [Abstract][Full Text] [Related]
43. Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin.
Beyer-Sehlmeyer G; Hiddemann W; Wörmann B; Bertram J
Eur J Cancer; 1999 Nov; 35(12):1735-42. PubMed ID: 10674022
[TBL] [Abstract][Full Text] [Related]
44. Expression profiling and putative mechanisms of resistance to doxorubicin of human lung cancer cells.
Kashkin KN; Musatkina EA; Komelkov AV; Favorskaya IA; Trushkin EV; Shleptsova VA; Sakharov DA; Vinogradova TV; Kopantzev EP; Zinovyeva MV; Kovaleva OV; Zborovskaya IB; Tonevitsky AG; Sverdlov ED
Dokl Biochem Biophys; 2010; 430():20-3. PubMed ID: 20380156
[No Abstract] [Full Text] [Related]
45. Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells.
Efeoglu E; Henry M; Clynes M; Meleady P
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291610
[TBL] [Abstract][Full Text] [Related]
46. Establishment of two new multi-drug resistant variants of the human tumor line Hep-2.
Redmond A; Law E; Gilvarry U; Clynes M
Cell Biol Toxicol; 1990 Jul; 6(3):293-302. PubMed ID: 2253054
[TBL] [Abstract][Full Text] [Related]
47. [Research advances of artemin].
Xun G; Guo F; Li Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2011 Oct; 14(10):790-800. PubMed ID: 22008109
[No Abstract] [Full Text] [Related]
48. Airway Basal Cell Heterogeneity and Lung Squamous Cell Carcinoma.
Hynds RE; Janes SM
Cancer Prev Res (Phila); 2017 Sep; 10(9):491-493. PubMed ID: 28821543
[TBL] [Abstract][Full Text] [Related]
49. Re: Human Schlafen 5 (SLFN5) is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells.
Atala A
J Urol; 2016 Apr; 195(4 Pt 1):1169. PubMed ID: 27302824
[No Abstract] [Full Text] [Related]
50. Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells.
Mahgoub TM; Jordan EJ; Mahdi AF; Oettl V; Huefner S; O'Donovan N; Crown J; Collins DM
Cancer Chemother Pharmacol; 2024 May; 93(5):427-437. PubMed ID: 38226983
[TBL] [Abstract][Full Text] [Related]
51. PepAnalyzer: predicting peptide properties using its sequence.
Rustagi V; Gupta SRR; Bajaj M; Singh A; Singh IK
Amino Acids; 2023 Oct; 55(10):1371-1379. PubMed ID: 37668712
[TBL] [Abstract][Full Text] [Related]
52. New Insights into the Role of Endoplasmic Reticulum Stress in Breast Cancer Metastasis.
Han CC; Wan FS
J Breast Cancer; 2018 Dec; 21(4):354-362. PubMed ID: 30607156
[TBL] [Abstract][Full Text] [Related]
53. Mitomycin C treatment induces resistance and enhanced migration via phosphorylated Akt in aggressive lung cancer cells.
Shen CY; Chen LH; Lin YF; Lai LC; Chuang EY; Tsai MH
Oncotarget; 2016 Nov; 7(48):79995-80007. PubMed ID: 27833080
[TBL] [Abstract][Full Text] [Related]
54. Elevated STAT3 Signaling-Mediated Upregulation of MMP-2/9 Confers Enhanced Invasion Ability in Multidrug-Resistant Breast Cancer Cells.
Zhang F; Wang Z; Fan Y; Xu Q; Ji W; Tian R; Niu R
Int J Mol Sci; 2015 Oct; 16(10):24772-90. PubMed ID: 26501276
[TBL] [Abstract][Full Text] [Related]
55. Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivo.
Ogbomo H; Zemp FJ; Lun X; Zhang J; Stack D; Rahman MM; McFadden G; Mody CH; Forsyth PA
PLoS One; 2013; 8(6):e66825. PubMed ID: 23762498
[TBL] [Abstract][Full Text] [Related]
56. Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells.
Barancik M; Bohacova V; Gibalova L; Sedlak J; Sulova Z; Breier A
Int J Mol Sci; 2012; 13(1):369-82. PubMed ID: 22312258
[TBL] [Abstract][Full Text] [Related]
57. Involvement of MMP-2 in adriamycin resistance dependent on ERK1/2 signal pathway in human osteosarcoma MG-63 cells.
Ren Y; Guo F; Chen A; Deng R; Wang J
J Huazhong Univ Sci Technolog Med Sci; 2012 Feb; 32(1):82-86. PubMed ID: 22282250
[TBL] [Abstract][Full Text] [Related]
58. Discovery of IL-18 as a novel secreted protein contributing to doxorubicin resistance by comparative secretome analysis of MCF-7 and MCF-7/Dox.
Yao L; Zhang Y; Chen K; Hu X; Xu LX
PLoS One; 2011; 6(9):e24684. PubMed ID: 21931812
[TBL] [Abstract][Full Text] [Related]
59. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.
Stewart DJ
Crit Rev Oncol Hematol; 2010 Sep; 75(3):173-234. PubMed ID: 20047843
[TBL] [Abstract][Full Text] [Related]
60. Is resistance useless? Multidrug resistance and collateral sensitivity.
Hall MD; Handley MD; Gottesman MM
Trends Pharmacol Sci; 2009 Oct; 30(10):546-56. PubMed ID: 19762091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
